Giant Biogene Holding Co. Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
2,668.00
1,928.00
1,369.00
1,172.00
1,093.00
767.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-28.00
141.00
-153.00
-66.00
142.00
42.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
2,333.00
1,872.00
1,098.00
845.00
948.00
762.00
Cash Flow from Investing Activities
-1,314.00
-625.00
-1,009.00
1,790.00
-624.00
-695.00
Cash Flow from Financing Activities
626.00
47.00
-6,737.00
5,476.00
8.00
5.00
Net Cash Inflow / Outflow
1,654.00
1,296.00
-6,712.00
8,117.00
332.00
73.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
8.00
1.00
-64.00
4.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Giant Biogene Holding Co. Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
2668.65977586739
1730.77721395932
938.00
54.19%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-28.4522020750002
-807.170622052932
779.00
96.48%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
2333.84494795898
2210.31525635904
123.00
5.59%
Cash Flow from Investing Activities
-1314.69513625786
-1587.34676278902
273.00
17.18%
Cash Flow from Financing Activities
626.733423711978
-961.281793517981
1,587.00
165.20%
Net Cash Inflow / Outflow
1654.75110222094
-252.180374489158
1,906.00
756.18%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
8.86786680784341
86.1329254588046
-78.00
-89.70%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 24.61% vs 70.47% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
2,333.84
1,872.89
24.61%






